Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Looking Past the Short Term
29
Mar 28, 2008 07:47AM

I agree with everything said except I am concerned about creating too high of an expectation regarding not only what the numbers are in April, but what effect the numbers will have on the stock price.  I believe the April numbers will merely confirm what most of us already know.  Yes if they are big enough it may get the rest of the investment community to take notice and we might see some added activity but I would hate to see people jumping ship if the stock does not take off as they expect just on news of the earnings that most of already have a good idea about. 

As I have said before I do not expect "the big cashendo" until that money is put to use with a solid M&A as the company has been stating is its intention or if we start seeing ongoing royalties.  I would love to be wrong and see some major movement before then but I doubt it.  It takes a lot of work to appreciate the long term value of this company.  Most investors do not care to put in that much work.  On the surface we are a penny stock with almost 400 million shares outstanding, no tangible product and still some lingering questions about the validity of our patents.  A M&A with a company that has an ongoing tangible business and a NASDQ listing will change everything with how this company is perceived by the general investment community.  Add in the continued pursuant of licensing fees and we will all be sitting pretty.  

Share
New Message
Please login to post a reply